PLGLA: A Potential Drug Target and Biomarker (G285189)

Target Name: PLGLA

NCBI ID: G285189

PLGLA

Other Name(s): plasminogen like A (pseudogene) | PLGLA1 | Plasminogen like A (pseudogene) | PLGP2 | PRGA

PLGLA: A Potential Drug Target and Biomarker

Plasminogen-like A (PLGA) is a pseudogene that is found in the blood of humans, as well as many other animals, including humans. It is a protein that is similar to plasminogen, which is a protein that is involved in the body's clotting mechanism. PLGA has been shown to be involved in a number of different processes in the body, including blood clotting, tissue repair, and inflammation. As a result, PLGA has potential as a drug target and biomarker.

One of the key features of PLGA is its ability to interact with certain proteins, including the A2A adenosine receptor. This interaction allows PLGA to influence the body's clotting mechanisms, which is important for preventing blood clots. In addition, PLGA has been shown to interact with the protein PDGF-BB, which is involved in tissue repair and regeneration.

PLGA has also been shown to be involved in inflammation, which is important for many different functions in the body. For example, it has been shown to play a role in the regulation of pain, and it has been shown to influence the immune system.

Despite its potential as a drug target and biomarker, PLGA has not yet been studied extensively in the laboratory or in clinical trials. As a result, it is not yet clear fully how it works and what its potential therapeutic benefits and risks are. However, research into PLGA is an exciting area, and it has the potential to lead to new and effective treatments for a variety of diseases.

Protein Name: Plasminogen Like A (pseudogene)

Functions: May bind non-covalently to lysine binding sites present in the kringle structures of plasminogen. This may interfere with the binding of fibrin or alpha-2-antiplasmin to plasminogen and may result in the localization of activity at sites necessary for extracellular matrix destruction (By similarity)

The "PLGLA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLGLA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets